CHARCOT-MARIE-TOOTH SUBTYPE BIOMARKERS AND OUTCOME MEASURES IN SUBJECTS WITH CMT1B, CMT2A, CMT2F AND CMT1X

被引：0
|
作者：
Dragon, Amanda [1 ]
Reilly, Mary [2 ]
Svaren, John [3 ]
Scherer, Steven [4 ]
Pareyson, Davide [5 ]
Herrmann, David [6 ]
Shy, Michael E. [1 ]
机构：
[1] Univ Iowa, Carver Coll Med, Iowa City, IA USA
[2] UCL Queen Sq Inst Neurol, London, England
[3] Univ Wisconsin Madison, Madison, WI USA
[4] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[6] Univ Rochester, Dept Neurol, Rochester, MN USA
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2024年 / 29卷
关键词：
CMT; Charcot-Marie-Tooth; neuropathy;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P 044
引用
收藏
页码：S17 / S18
页数：2
相关论文
共 50 条
  • [1] MRI MEASURED DIXON FAT FRACTION IS A RESPONSIVE OUTCOME MEASURE IN CMT1X, CMT1B AND CMT2A
    Doherty, Carolynne
    Howard, Paige
    Zuccarino, Riccardo
    Wastling, Stephen
    Pipis, Menelaos
    Zafeiropoulos, Nick
    Stephens, Katherine
    Grider, Tiffany
    Feely, Shawna
    Nopoulos, Peggy
    Skorupinska, Mariola
    Milev, Evelin
    Nicolaisen, Emma
    McDowell, Amy
    Rossor, Alexander
    Shah, Sachit
    laura, MatilDe
    Thedens, Daniel
    Thornton, John
    Morrow, Jasper
    Shy, Michael
    Reilly, Mary
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S37 - S37
  • [2] Linkage mapping of the gene for Charcot-Marie-Tooth disease type 2 to chromosome 1p (CMT2A) and the clinical features of CMT2A
    Saito, M
    Hayashi, Y
    Suzuki, T
    Tanaka, H
    Hozumi, I
    Tsuji, S
    NEUROLOGY, 1997, 49 (06) : 1630 - 1635
  • [3] Charcot-Marie-Tooth disease (CMT): distinctive phenotypic and genotypic features in CMT type 2
    Gemignani, F
    Marbini, A
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 184 (01) : 1 - 9
  • [4] Mutation analysis of the CMT2A locus in Charcot-Marie-Tooth type 2 cases
    Züchner, S
    Mersiyanova, IV
    Senderek, J
    Polyakov, AV
    Dadali, EL
    Bergmann, C
    Schröder, JM
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 : S64 - S64
  • [5] SENSITIVE OUTCOME MEASURES IN CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A) NEUROPATHY
    Mori, L.
    Francini, L.
    Prada, V
    Signori, A.
    Accogli, S.
    Bragadin, Monti M.
    Bolla, S.
    Pareyson, D.
    Padua, L.
    Fabrizi, G.
    Schenone, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2016, 21 : S21 - S21
  • [6] Altered Lipid Biosynthesis in Charcot-Marie-Tooth Disease Type 2A (CMT2A)
    Zuchner, Stephan
    NEUROLOGY, 2011, 76 (09) : A454 - A455
  • [7] CMTNS AND OTHER OUTCOME MEASURES IN CHARCOT-MARIE-TOOTH DISEASE TYPE 1A (CMT1A): DATA FROM THE TRIALS WITH ASCORBIC AACID (CMT-TRIAAL AND CMT-TRAUK)
    Pareyson, D.
    Schenone, A.
    Fabrizi, G. M.
    Santoro, L.
    Quattrone, A.
    Vita, G.
    Padua, L.
    Gemignani, F.
    Reilly, M. M.
    Solari, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2009, 14 : 21 - 22
  • [8] Novel mutations and genotype: Phenotype correlation in Charcot-Marie-Tooth type 1B (CMT1B)
    Abe, KT
    Magrin, MT
    Pavanello, RCM
    Marchiori, PE
    Zatz, M
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 567 - 567
  • [9] CHARCOT-MARIE-TOOTH TYPE I DISEASE (CMT-1)
    Adoukonou, Thierry Armel
    Vallat, Jean-Michel
    Mathis, Stephane
    AFRICAN JOURNAL OF NEUROLOGICAL SCIENCES, 2015, 34 (01): : 72 - 84
  • [10] Charcot-Marie-Tooth disease: correction of the CMT-1A phenotype
    Davies, Shelley L.
    Moral, M. Angels
    DRUGS OF THE FUTURE, 2006, 31 (06) : 531 - 533
12345